Imunon (IMNN) GC Susan Eylward Receives Award, Sells 2,525 Shares

What Happened Susan Eylward, General Counsel and Corporate Secretary of Imunon, Inc. (IMNN), was granted 2,525 shares on 2026-08-28 as stock paid in lieu of cash compensation (worth $1.60/share, $4,040). She then disposed of 2,525 shares in an open-market sale on 2026-08-31 for a weighted average price of $1.5643/share (total proceeds ~$3,950). The two transactions effectively offset one another (grant then sale); the grant was compensation rather than a market purchase.

Key Details

• Grant: 2,525 shares on 2026-08-28 at $1.60/share; reported value $4,040. (Footnote F1: stock granted in lieu of cash for portion of base salary.)
• Sale: 2,525 shares on 2026-08-31; weighted average sale price $1.5643/share, range $1.55–$1.58; total proceeds ~$3,950. (Footnote F2: per-share breakdown available on request.)
• Net cash difference between grant value and sale proceeds: about -$90 (does not account for broker fees/taxes).
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Filing: Form 4 filed 2026-09-01 covering the 8/28 and 8/31 transactions; filing appears to be timely based on the reported dates.

Context

• The grant was compensation (stock in lieu of salary), which is a routine corporate action and not necessarily a signal of insider market view. The subsequent quick open-market sale likely reflects disposition of compensation shares rather than a traditional investment sell decision.
• No 10b5-1 plan, gifts, or option exercises are indicated in the provided details.